MYRIAD GENETICS, INC. Payments to Acquire Marketable Securities
MYRIAD GENETICS, INC. (MYGN) reported Payments to Acquire Marketable Securities of $80.70 million for the 12-month period ending 2015-06-30, per its 10-K filed 2015-08-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2015-08-12
- MYRIAD GENETICS, INC. payments to acquire marketable securities for the quarter ending 2015-06-30 was $25.63M, a 54.51% decline year-over-year.
- MYRIAD GENETICS, INC. payments to acquire marketable securities for the quarter ending 2015-03-31 was $32.45M, a 1062.94% increase year-over-year.
- MYRIAD GENETICS, INC. payments to acquire marketable securities for the quarter ending 2014-12-31 was $16.75M, a 60.60% decline year-over-year.
- MYRIAD GENETICS, INC. payments to acquire marketable securities for the quarter ending 2014-09-30 was $5.87M, a 90.24% decline year-over-year.
- MYRIAD GENETICS, INC. payments to acquire marketable securities for fiscal 2015 was $80.70M, a 50.12% decline from fiscal 2014.
- MYRIAD GENETICS, INC. payments to acquire marketable securities for fiscal 2014 was $161.80M, a 63.54% decline from fiscal 2013.
- MYRIAD GENETICS, INC. payments to acquire marketable securities for fiscal 2013 was $443.80M, a 14.36% increase from fiscal 2012.
- MYRIAD GENETICS, INC. payments to acquire marketable securities for fiscal 2012 was $388.07M, a 8.72% decline from fiscal 2011.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|
| 2015-06-30 | $25.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $58.08M derived: sum of 2 quarters · filed 2015-08-12 | $74.83M derived: sum of 3 quarters · filed 2015-08-12 | $80.70M 10-K · filed 2015-08-12 | |
| 2015-03-31 | $32.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $49.20M derived: sum of 2 quarters · filed 2015-05-06 | $55.07M 10-Q · filed 2015-05-06 | $111.42M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2014-12-31 | $16.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-04 | $22.62M 10-Q · filed 2015-02-04 | $78.97M derived: sum of 3 quarters · filed 2015-08-12 | $81.76M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2014-09-30 | $5.87M 10-Q · filed 2014-11-05 | $62.22M derived: sum of 2 quarters · filed 2015-08-12 | $65.01M derived: sum of 3 quarters · filed 2015-08-12 | $107.53M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2014-06-30 | $56.35M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $59.14M derived: sum of 2 quarters · filed 2015-08-12 | $101.66M derived: sum of 3 quarters · filed 2015-08-12 | $161.80M 10-K · filed 2015-08-12 | $161.76M 10-K · filed 2014-08-13 |
| 2014-03-31 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $45.31M derived: sum of 2 quarters · filed 2015-05-06 | $105.45M 10-Q · filed 2015-05-06 | $267.48M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2013-12-31 | $42.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-04 | $102.66M 10-Q · filed 2015-02-04 | $264.69M derived: sum of 3 quarters · filed 2015-08-12 | $307.20M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2013-09-30 | $60.14M 10-Q · filed 2014-11-05 | $222.17M derived: sum of 2 quarters · filed 2015-08-12 | $264.68M derived: sum of 3 quarters · filed 2015-08-12 | $377.04M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2013-06-30 | $162.03M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $204.54M derived: sum of 2 quarters · filed 2015-08-12 | $316.90M derived: sum of 3 quarters · filed 2015-08-12 | $443.80M 10-K · filed 2015-08-12 | $443.78M 10-K · filed 2013-08-14 |
| 2013-03-31 | $42.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $154.87M derived: sum of 2 quarters · filed 2014-05-07 | $281.77M 10-Q · filed 2014-05-07 | $378.99M derived: sum of 4 quarters · filed 2014-08-13 | |
| 2012-12-31 | $112.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $239.26M 10-Q · filed 2014-02-05 | $336.48M derived: sum of 3 quarters · filed 2014-08-13 | $467.47M derived: sum of 4 quarters · filed 2014-08-13 | |
| 2012-09-30 | $126.90M 10-Q · filed 2013-11-12 | $224.12M derived: sum of 2 quarters · filed 2014-08-13 | $355.11M derived: sum of 3 quarters · filed 2014-08-13 | $473.69M derived: sum of 4 quarters · filed 2014-08-13 | |
| 2012-06-30 | $97.21M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $228.21M derived: sum of 2 quarters · filed 2014-08-13 | $346.79M derived: sum of 3 quarters · filed 2014-08-13 | $388.07M 10-K · filed 2014-08-13 | |
| 2012-03-31 | $131.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $249.57M derived: sum of 2 quarters · filed 2013-05-08 | $290.85M 10-Q · filed 2013-05-08 | $377.04M derived: sum of 4 quarters · filed 2013-08-14 | |
| 2011-12-31 | $118.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-06 | $159.86M 10-Q · filed 2013-02-06 | $246.05M derived: sum of 3 quarters · filed 2013-08-14 | $356.44M derived: sum of 4 quarters · filed 2013-08-14 | |
| 2011-09-30 | $41.28M 10-Q · filed 2012-11-09 | $127.47M derived: sum of 2 quarters · filed 2013-08-14 | $237.86M derived: sum of 3 quarters · filed 2013-08-14 | $418.92M derived: sum of 4 quarters · filed 2013-08-14 | |
| 2011-06-30 | $86.19M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $196.58M derived: sum of 2 quarters · filed 2013-08-14 | $377.63M derived: sum of 3 quarters · filed 2013-08-14 | $425.15M 10-K · filed 2013-08-14 | |
| 2011-03-31 | $110.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-02 | $291.44M derived: sum of 2 quarters · filed 2012-05-02 | $338.96M 10-Q · filed 2012-05-02 | $485.48M derived: sum of 4 quarters · filed 2012-08-15 | |
| 2010-12-31 | $181.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-01 | $228.57M 10-Q · filed 2012-02-01 | $375.09M derived: sum of 3 quarters · filed 2012-08-15 | $485.92M derived: sum of 4 quarters · filed 2012-08-15 | |
| 2010-09-30 | $47.52M 10-Q · filed 2011-11-02 | $194.04M derived: sum of 2 quarters · filed 2012-08-15 | $304.87M derived: sum of 3 quarters · filed 2012-08-15 | $469.91M derived: sum of 4 quarters · filed 2012-08-15 | |
| 2010-06-30 | $146.52M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-15 | $257.35M derived: sum of 2 quarters · filed 2012-08-15 | $422.39M derived: sum of 3 quarters · filed 2012-08-15 | $477.56M 10-K · filed 2012-08-15 | |
| 2010-03-31 | $110.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-05-04 | $275.87M derived: sum of 2 quarters · filed 2011-05-04 | $331.04M 10-Q · filed 2011-05-04 | ||
| 2009-12-31 | $165.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-02-01 | $220.21M 10-Q · filed 2011-02-01 | |||
| 2009-09-30 | $55.17M 10-Q · filed 2010-11-03 | ||||
| 2009-06-30 | $308.57M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |